30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Used to detect whether BEND2 (Xp22) has undergone a break. In 2019, a literature report indicated that whole-genome sequencing analysis revealed CHD7-BEND2 fusions in a group of well-differentiated grade 3 pancreatic neuroendocrine tumors (PanNETs). Additionally, in 2017, the ICGC study identified two cases of grade 3 PanNETs with EWSR1-BEND2 fusions. Additionally, MN1-BEND2 fusions have been identified in central nervous system PNETs.